Humedix Co., Ltd. (KOSDAQ:200670)

Market Cap	521.17B
Revenue (ttm)	110.99B
Net Income (ttm)	9.06B
Shares Out	10.32M
EPS (ttm)	963.99
PE Ratio	52.39
Forward PE	11.10
Dividend	660.00 (1.30%)
Ex-Dividend Date	Aug 20, 2025

Volume	99,894
Average Volume	158,246
Open	50,800
Previous Close	50,800
Day's Range	50,300 - 51,800
52-Week Range	25,400 - 77,200
Beta	0.41
RSI	41.58
Earnings Date	Nov 10, 2025

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.